Mark Heinen
Vermogen: 9 869 $ op 30-06-2026
Vermogen: 9 869 $ op 30-06-2026
Mark Heinen currently works at Volato Group, Inc., as Chief Financial Officer from 2023.
Mr. Heinen also formerly worked at Daegis, Inc., as Chief Financial Officer from 2013 to 2016, Trintech, Inc., as CFO & Senior VP-Global Corporate Controller from 2017 to 2019, Better Therapeutics, Inc., as Chief Financial Officer & Head-Finance from 2021 to 2023, and Omnigo LLC, as Chief Financial Officer.
Mr. Heinen received his undergraduate degree and Masters Business Admin degree from the University of Oklahoma.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
0,19% | 21-04-2026 | 60.921 ( 0,19% ) | 9 869 $ | 30-06-2026 |
| Bedrijven | Functie | Begin |
|---|
| Bedrijven | Functie | Einde |
|---|---|---|
| BETTER THERAPEUTICS, INC. | Financieel Directeur/CFO | 27-11-2023 |
Trintech, Inc.
Trintech, Inc. Packaged SoftwareTechnology Services Provides account reconciliation and payment infrastructure software solutions | Financieel Directeur/CFO | 10-09-2019 |
| DAEGIS INC | Financieel Directeur/CFO | 01-01-2016 |
Omnigo LLC | Financieel Directeur/CFO | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
University of Oklahoma
University of Oklahoma Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Trintech, Inc.
Trintech, Inc. Packaged SoftwareTechnology Services Provides account reconciliation and payment infrastructure software solutions | Technology Services |
Daegis, Inc.
Daegis, Inc. Packaged SoftwareTechnology Services Provides application development, data management, migration and archiving software solutions | Technology Services |
Better Therapeutics, Inc.
Better Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops prescription digital therapeutics for the treatment of cardiovascular and metabolic diseases | Health Technology |
Omnigo LLC |
Kies jouw editie
Alle financiële informatie op nationaal niveau